Latest News and Press Releases
Want to stay updated on the latest news?
-
Pharming Group reports Q3 2025 results with significant growth in revenue, profit, and cash flow driven by rare disease portfolio performance.
Want to stay updated on the latest news?
Pharming Group reports Q3 2025 results with significant growth in revenue, profit, and cash flow driven by rare disease portfolio performance.